Patent details

Basic Information

Publication number:

EP3244912

PCT Application Number:

EP2016050804

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167007582

PCT Publication Number:

WO2016113404

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS WITH LIXISENATIDE

French Title of Invention:

TRAITEMENT AVEC LIXISENATIDE DE PATIENTS PEDIATRIQUES AYANT DIABETES MELLITUS TYPE 2

German Title of Invention:

BEHANDLUNG VON PEDIATRISCHEN TYP-2-DIABETES MELLITUS PATIENTEN MIT LIXISENATIDE

SPC Number:

Dates

Filing date:

15/01/2016

Grant date:

18/08/2021

EP Publication Date:

22/11/2017

PCT Publication Date:

21/07/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

18/08/2021

EP B1 Publication Date:

18/08/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/01/2022

Expiration date:

15/01/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/08/2021

 

 

Name:

Sanofi-Aventis Deutschland GmbH

Address:

Brüningstraße 50, 65929 Frankfurt am Main, Germany (DE)

Inventor

1

Name:

BERGMANN, Karin

Address:

Germany (DE)

2

Name:

JAN, Christelle

Address:

France (FR)

3

Name:

HINCELIN-MÉRY, Agnès

Address:

France (FR)

Priority

Priority Number:

15151488

Priority Date:

16/01/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 38/26; A61P 3/10;

Publication

European Patent Bulletin

Issue number:

202133

Publication date:

18/08/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages